A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target.

by Daniel M Appledorn, Yasser A Aldhamen, William Depas, Sergey S Seregin, Chyong-Jy J Liu, Nathan Schuldt, Darin Quach, Dionisia Quiroga, Sarah Godbehere, Igor Zlatkin, Sungjin Kim, J Justin McCormick, Andrea Amalfitano
Published 2010-03-01